Creating proteins with Intelligent Architecture™ for health and sustainable manufacturing
Creating proteins with Intelligent Architecture™ for health and sustainable manufacturing
Sector: Synthetic biology / computational protein design
Product: Intelligent Architecture™ platform; LYNX Enzyme Optimization™
Recent funding: €6.5M seed (announced 2024-08-05)
Team size: ~30 employees
Headquarters: Vilnius, Lithuania
Computational protein and enzyme design to enable faster, more efficient development of proteins for health and industrial uses.
Biotechnology
€6,500,000
Participants listed include Inventure, Practica Capital and Metaplanet.
“Backed by regional VCs including UVC Partners and Inventure”